376 related articles for article (PubMed ID: 9750204)
1. Efficacy and safety of estrogen/androgen therapy. Menopausal symptoms, bone, and cardiovascular parameters.
Barrett-Connor E
J Reprod Med; 1998 Aug; 43(8 Suppl):746-52. PubMed ID: 9750204
[No Abstract] [Full Text] [Related]
2. Practical clinical considerations in the use of estrogen/androgen therapy. A case-based forum.
Metzger DA; Chosak R; Leventhal J; Young RL
J Reprod Med; 1998 Aug; 43(8 Suppl):753-62. PubMed ID: 9750205
[No Abstract] [Full Text] [Related]
3. Effects of estrogen/androgen therapy on bone mineral density parameters.
Notelovitz M
J Reprod Med; 2001 Mar; 46(3 Suppl):325-31. PubMed ID: 11304880
[TBL] [Abstract][Full Text] [Related]
4. Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies.
Sherwin BB
Int J Fertil Womens Med; 1998; 43(2):98-103. PubMed ID: 9609209
[TBL] [Abstract][Full Text] [Related]
5. Androgen replacement in menopause.
Burd ID; Bachmann GA
Curr Womens Health Rep; 2001 Dec; 1(3):202-5. PubMed ID: 12112971
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.
Watts NB; Notelovitz M; Timmons MC; Addison WA; Wiita B; Downey LJ
Obstet Gynecol; 1995 Apr; 85(4):529-37. PubMed ID: 7898828
[TBL] [Abstract][Full Text] [Related]
7. [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system].
Kornacewicz-Jach Z; Czarnecka D; Rynkiewicz A; Kotarski J; Paszkowski T; Pertyński T; Debski R; Wielgoś M
Kardiol Pol; 2009 Jan; 67(1):72-6. PubMed ID: 19253195
[No Abstract] [Full Text] [Related]
8. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
[TBL] [Abstract][Full Text] [Related]
9. Physiologic aspects of natural and surgical menopause.
Bachmann G
J Reprod Med; 2001 Mar; 46(3 Suppl):307-15. PubMed ID: 11310451
[TBL] [Abstract][Full Text] [Related]
10. Potential anabolic effects of androgens on bone.
Kearns AE; Khosla S
Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S14-8. PubMed ID: 15065633
[TBL] [Abstract][Full Text] [Related]
11. Estrogens and disease prevention.
Moon TE
Arch Intern Med; 1991 Jan; 151(1):17-8. PubMed ID: 1985592
[No Abstract] [Full Text] [Related]
12. Estrogen therapy during menopause and the treatment of osteoporosis.
Noyes MA; Demmler RW
Prim Care; 1990 Sep; 17(3):647-66. PubMed ID: 2236341
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
[TBL] [Abstract][Full Text] [Related]
14. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
15. Use of alternatives to estrogen for treatment of menopause.
Pinkerton JV; Santen R
Minerva Endocrinol; 2002 Mar; 27(1):21-41. PubMed ID: 11845111
[TBL] [Abstract][Full Text] [Related]
16. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and efficacy of different estrogens are not equivalent.
Ansbacher R
Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
[TBL] [Abstract][Full Text] [Related]
18. Estrogen therapy during menopause.
Horwitz DL
Compr Ther; 1980 Mar; 6(3):3-4. PubMed ID: 7363581
[TBL] [Abstract][Full Text] [Related]
19. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Shulman LP
J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
[No Abstract] [Full Text] [Related]
20. Variations on traditional HRT. The estrogen-androgen option.
Norman DJ
Adv Nurse Pract; 1997 Nov; 5(11):34-7. PubMed ID: 9459999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
